Acceleration of G1cooperates with core binding factor β-smooth muscle myosin heavy chain to induce acute leukemia in mice

Cancer Research

Volumn 62, Issue 8, 2002, Pages 2232-2235

  Yang, Yandan ^a   Wang, Weihua ^a   Cleaves, Rebecca ^a   Zahurak, Marianna ^a   Cheng, Linzhao ^a   Civin, Curt I ^a   Friedman, Alan D ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORE BINDING FACTOR; CORE BINDING FACTOR BETA; MYOSIN HEAVY CHAIN; ONCOPROTEIN; PROTEIN E7; PROTEIN P16; PROTEIN P19; UNCLASSIFIED DRUG;

ACUTE LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL CYCLE G1 PHASE; CLONAL VARIATION; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; GENE MUTATION; GENETIC TRANSDUCTION; ISOGRAFT; KAPLAN MEIER METHOD; LEUKEMOGENESIS; MOUSE; MYELOID LEUKEMIA; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; SMOOTH MUSCLE;

ACUTE DISEASE; ANIMALS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA-BINDING PROTEINS; G1 PHASE; LEUKEMIA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MYOSIN HEAVY CHAINS; ONCOGENE PROTEINS, VIRAL; RETROVIRIDAE; SMOOTH MUSCLE MYOSINS; TRANSCRIPTION FACTOR AP-2; TRANSCRIPTION FACTORS; TRANSDUCTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P14ARF;

EID: 0037089563     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Leukemogenesis by CBF oncoproteins
2. The fusion gene Cbfb-MYH11 blocks myeloid differentiation and predisposes mice to acute myelomonocytic leukemia
3. Expression of a conditional AML1-ETO oncogene by-passes embryonic lethality and establishes a murinee model of t(8;21) acute myeloid leukemia
4. AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations
5. Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission
6. III, and Friedman, A. D. Exogenous cdk4 overcomes reduced cdk4 RNA and inhibition of G1 progression in hematopoietic cells expressing a dominant-negative CBF-a model for overcoming inhibition of proliferation by CBF oncoproteins
7. CBFβ-SMMHC, expressed in M4eo AML, reduces p53 induction and slows apoptosis in hematopoietic cells exposed to DNA-damaging agents
8. Friedman expressed in M4eo AML, reduced CBF DNA-binding and inhibited the G 1 to S cell cycle transition at the restriction point in myeloid and lymphoid cells
9. The core binding factor α interaction domain and the smooth muscle myosin heavy chain segment of CBFβ-SMMHC are both required to slow cell proliferation
10. Expression of the AML-1 oncogene shortens the G1 phase of the cell cycle
11. Dichotomy of AML1-ETO functions: Growth arrest versus block of differentiation
12. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges
13. Role of the INK4a locus in tumor suppression and cell mortality
14. Growth factor modulation of p53-mediated growth arrest versus apoptosis
15. p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein
16. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF
17. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis
18. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15(INK4B1)
19. Localization of amplified MYC gene sequences to double minute chromosomes in acute myelogenous leukemia